Honorary Consultant Clinical Oncologist, MD MRCP FRCR

Oncology, Division B

Telephone: 01223 586705 (secretary)

GMC number: 4153627

Professional bodies:

  • Royal College of Radiologists

Specialty: Neuro-oncology


Dr Jena is a neuro-oncologist and he provides radiotherapy and drug treatments for tumours of the brain and spine. He has specific interests in stereotactic radiosurgery, the use of Avastin for patients with NF2, and in radiotherapy re-treatment.

Papers and publications (top 5 papers):

  1. Exploiting biological and physical determinants of radiotherapy toxicity to individualise treatment. Scaife JE, Barnett GG, Noble DJ, Jena R, Thomas SJ, West CM, Burnet NG. Br J Radiol. 2015 May 26:20150172
  2. Barazzuol L, Jena R, Burnet NG, Meira LB, Jeynes JC, Kirkby KJ, Kirkby NF. Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma. Radiat Oncol. 2013 Mar 19;8:65.  
  3. Mukesh M, Harris E, Collete S, Coles CE, Bartelink H, Wilkinson J, Evans PM, Graham P, Havilland J, Poortmans P, Yarnold J, Jena R. Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials. Radiother Oncol. 2013 Aug;108(2):293-8. 
  4. Jena R, Mee T, Kirkby NF, Williams MV. Quantifying Uncertainty in Radiotherapy Demand at the Local and National Level using the Malthus Model.  Clin Oncol (R Coll Radiol). 2015 Feb;27(2):92-8.
  5. Zikic D, Glocker B, Konukoglu E, Criminisi A, Demiralp C, Shotton J, Thomas OM, Das T, Jena R, Price SJ. Decision forests for tissue-specific segmentation of high-grade gliomas in multi-channel MR. Med Image Comput Comput Assist Interv. 2012;15(Pt 3):369-76.
Show on hub page: